Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study

1. Sánchez, M.A.
2. Marín, F.
3. Masjuan, J.
4. Cosín-Sales, J.
5. Rodríguez, J.M.V.
6. Barrios, V.
7. Barón-Esquivias, G.
8. Lekuona, I.
9. Pérez-Cabeza, A.I.
10. Freixa-Pamias, R.
11. Jimenez, F.J.P.
12. Khatib, M.M.K.
13. Priu, C.R.
14. Fernández, M.S.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.5603/CJ.A2022.0091 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus